Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-06 2020-09-04 121903
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2020-08-26 2020-09-02 122994
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-16 2019-11-18 96647
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-15 2024-10-11 235345
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-09-12 2024-10-11 237378
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-11 2018-08-01 55299
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-04 196300
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-04 199527
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-03-02 184086
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-08-04 195091
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-09 2025-01-24 247391
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-09 2025-01-31 247394
APO-FINASTERIDE 5MG TABLET Actual shortage 2024-01-19 2024-02-16 216684
APO-FINASTERIDE 5MG TABLET Resolved 2019-04-04 2019-08-02 80533
APO-FINASTERIDE 5MG TABLET Resolved 2017-06-19 2017-07-19 13317
APO-FINASTERIDE 5MG TABLET Resolved 2019-09-12 2019-10-01 93671
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN - TAB 500MG 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257